10-Q: TerrAscend Corp. Reports Q1 2025 Financial Results: Revenue Declines Amidst Competitive Pressures

TerrAscend Corp.'s Q1 2025 revenue decreased by 12% year-over-year, primarily due to lower retail sales in Michigan and New Jersey.

Summary

• TerrAscend Corp. reported a net revenue of $70.997 million for the three months ended March 31, 2025, a decrease of 12% compared to $80.633 million for the same period in 2024.
• The decrease in revenue was primarily driven by a decline in retail sales in Michigan and New Jersey, which was partially offset by higher sales in Maryland.
• Cost of sales decreased by 18% to $34.194 million, with cost of sales as a percentage of revenue decreasing to 48% due to lower unit costs in New Jersey and greater cost absorption in Maryland.
• General and administrative expenses decreased by 6% to $26.380 million due to the company's operating expense reduction initiative.
• The company reported a net loss of $12.269 million, compared to a net loss of $14.851 million in the same period last year.
• Adjusted EBITDA was $15.326 million, compared to $16.234 million for the three months ended March 31, 2024.
• The company repurchased 507,500 common shares for approximately $231,000 under its share repurchase program.
• As of March 31, 2025, the company had $29.248 million in cash and cash equivalents and $203.564 million in loans payable.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While revenue declined, the company is taking steps to manage costs and expand its operations through acquisitions. The overall outlook is cautiously optimistic.

Positives

• Cost of sales as a percentage of revenue decreased, indicating improved efficiency.
• General and administrative expenses decreased due to cost reduction initiatives.
• The company continues to execute its share repurchase program.
• TerrAscend completed the acquisition of certain assets of Ratio Cannabis LLC in Ohio on May 6, 2025, for $10.3 million.
• The company signed an option agreement to acquire Union Chill Cannabis Company LLC in New Jersey on May 5, 2025, for $13 million.

Negatives

• Revenue decreased by 12% year-over-year, primarily due to lower retail sales in Michigan and New Jersey.
• The company reported a net loss of $12.269 million.
• Unrealized and realized loss on investments of $742,000 due to write-off of an investment that was deemed no longer recoverable.

Risks

• The cannabis industry is subject to evolving federal, state, and local laws and regulations.
• The company faces competitive pressures in the markets in which it operates.
• The company's ability to achieve profitability depends on its ability to manage costs and increase revenue.
• The use of cannabis remains illegal under U.S. federal law, which could impact the company's operations.

Future Outlook

The company expects that G&A expenses will increase in absolute dollars as the business grows. The company expects to fund any additional future requirements through cash from ongoing operations, market offerings, additional debt, sale of real property, sale leaseback transactions, and exercise of options and warrants.

Industry Context

The report indicates increased competitive pressure in key markets like New Jersey, reflecting the ongoing evolution and maturation of the cannabis industry. Companies are facing the need to optimize operations and manage costs to maintain profitability in this environment.

Comparison to Industry Standards

• Without specific competitor data within this document, a detailed comparison to industry standards is limited.
• However, the report's focus on cost reduction and operational efficiency aligns with broader industry trends as cannabis companies seek to improve profitability.
• Companies like Curaleaf, Green Thumb Industries, and Trulieve are often considered benchmarks in the cannabis industry, and comparing TerrAscend's revenue growth, EBITDA margins, and cash flow to these companies would provide a more comprehensive assessment.

Legal Proceedings

• In the ordinary course of business, the Company is involved in a number of lawsuits incidental to its business, including litigation related to intellectual property, employment, and commercial matters.
• Although it is difficult to predict the ultimate outcome of these matters, management believes that any ultimate liability would not have a material adverse effect on the Consolidated Balance Sheets or unaudited interim condensed consolidated statements of operations and comprehensive loss.
• At March 31, 2025, there were no pending lawsuits that could reasonably be expected to have a material effect on the results of the Company's Consolidated Financial Statements.

Related Party Transactions

• As of March 31, 2025, certain funds controlled by Jason Wild, a related party of the Company, held $5,500 of the total loan principal balance of the FG Loan, as a member of the loan syndicate.

Stakeholder Impact

• Shareholders may be concerned about the decline in revenue and net loss.
• Employees may be affected by cost reduction initiatives.
• Customers may see changes in product offerings and pricing due to market competition.
• Suppliers and creditors may be impacted by the company's financial performance and ability to meet its obligations.

Next Steps

• The company will continue to execute its share repurchase program.
• The company will work to close the acquisition of Union Chill Cannabis Company LLC in New Jersey.
• The company will integrate the assets acquired from Ratio Cannabis LLC in Ohio.

Key Dates

Keywords

TerrAscend, cannabis, financial results, Q1 2025, revenue, EBITDA, share repurchase, acquisition, dispensaries, retail, wholesale